Detailansicht

Wissensnetz

Person

Henning Reis (1981-)

Arzt

Name	Henning Reis
Zeit	1981- (Lebensdaten)
Ort	Wesel (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr.
Beruf	Arzt
Beziehung	Universitätsklinikum Essen
Weitere Angaben	Diss. Fachbereich Medizin Privatdozent, Institut für Pathologie am Universitätsklinikum Essen
Quelle	Homepage: https://www.uk-essen.de/pathologie/index.php?load=15&sel=10&unt=15&op=15 (Stand: 20.04.2020) Homepage: https://www.researchgate.net/profile/Henning_Reis (Stand: 05.08.2020)
Datensatztyp	Person
GND-Nummer	140588655
Datensatz-ID	140588655
Beteiligt an alle anzeigen Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022 Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien : Automatische Quantifizierung von Leberverfettung Die Modelltransferierbarkeit von KI in der digitalen Pathologie : Potenzial und Realität Histomolekulare Klassifikation des Urothelkarzinoms der Harnblase : Vom histologischen Phänotyp zum Genotyp und zurück Der Einfluss eines vorbestehenden Diabetes Mellitus auf die Frühkontinenz nach radikaler Prostatektomie Die Rolle des Hypoxie-induzierbaren-Faktor 1α in der Pathogenese der Leberzirrhose und des Akut-auf-chronischen-Leberversagens Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies Histopathological, molecular and clinical profiling of lymphoepithelioma-like carcinoma of the bladder (LELC-B) Ovarialkarzinom: Molekularpathologie und molekular gesteuerte Therapie Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas CXCL1 and CXCL6 are potential predictors for HCC response to TACE Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Machine-learning-aided prediction of brain metastases development in non–small-cell lung cancers Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer Zeitverlauf bis zur Erstdiagnose bei Patienten mit GEP-NET : monozentrische Analyse Strukturierte Befundung am Beispiel des Prostatakarzinoms – Selbstentwicklung einer digitalen Lösung für Prostatastanzbiopsien Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better? Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort CK5/6 and GATA3 defined phenotypes of muscle-invasive bladder cancer: impact in adjuvant chemotherapy and molecular subtyping of negative cases Commentary: Treatment outcome of different chemotherapy in patients with relapsed or metastatic malignant urachal tumor Proteasomal processing immune escape mechanisms in platinum-treated advanced bladder cancer The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better? Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients Molecular Characterization of Muellerian Tumors of the Urinary Tract Angiomyolipom der Leber – Ein Fallbericht in Zusammenschau mit der Literatur Prevalence of APC and PTEN Alterations in Urachal Cancer Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study Prevalence of APC and PTEN Alterations in Urachal Cancer Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia–reperfusion injury and clinical outcome Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma Biologische Relevanz des GSα-T393C- [GSalpha-T393C-] und des Gβ3-C825T-Polymorphismus [Gbeta3-C825T-Polymorphismus] bei hepatisch metastasiertem kolorektalem Karzinom Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Henning Reis (1981-)

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien : Automatische Quantifizierung von Leberverfettung

Die Modelltransferierbarkeit von KI in der digitalen Pathologie : Potenzial und Realität

Histomolekulare Klassifikation des Urothelkarzinoms der Harnblase : Vom histologischen Phänotyp zum Genotyp und zurück

Der Einfluss eines vorbestehenden Diabetes Mellitus auf die Frühkontinenz nach radikaler Prostatektomie

Die Rolle des Hypoxie-induzierbaren-Faktor 1α in der Pathogenese der Leberzirrhose und des Akut-auf-chronischen-Leberversagens

Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies

Histopathological, molecular and clinical profiling of lymphoepithelioma-like carcinoma of the bladder (LELC-B)

Ovarialkarzinom: Molekularpathologie und molekular gesteuerte Therapie

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis

Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center

CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

CXCL1 and CXCL6 are potential predictors for HCC response to TACE

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Machine-learning-aided prediction of brain metastases development in non–small-cell lung cancers

Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer

Zeitverlauf bis zur Erstdiagnose bei Patienten mit GEP-NET : monozentrische Analyse

Strukturierte Befundung am Beispiel des Prostatakarzinoms – Selbstentwicklung einer digitalen Lösung für Prostatastanzbiopsien

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy

The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy

Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort

CK5/6 and GATA3 defined phenotypes of muscle-invasive bladder cancer: impact in adjuvant chemotherapy and molecular subtyping of negative cases

Commentary: Treatment outcome of different chemotherapy in patients with relapsed or metastatic malignant urachal tumor

Proteasomal processing immune escape mechanisms in platinum-treated advanced bladder cancer

The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients

Molecular Characterization of Muellerian Tumors of the Urinary Tract

Angiomyolipom der Leber – Ein Fallbericht in Zusammenschau mit der Literatur

Prevalence of APC and PTEN Alterations in Urachal Cancer

Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study

Prevalence of APC and PTEN Alterations in Urachal Cancer

Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer

Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer

Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer

Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma

The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer

Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder

Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels

Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC

Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival

Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis

Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions

Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia–reperfusion injury and clinical outcome

Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma

Biologische Relevanz des GSα-T393C- [GSalpha-T393C-] und des Gβ3-C825T-Polymorphismus [Gbeta3-C825T-Polymorphismus] bei hepatisch metastasiertem kolorektalem Karzinom

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma